Patrizia Mondello, MD, PhD, MSc¹, Brianna J Negaard, MS^2*, Luca Arcaini, MD^3*, Joshua Tobin^4*, Loic Chartier^5*, Brian K. Link, MD^6*, Andrew L. Feldman, MD⁷, Dai Chihara, MD, PhD⁸, Carla Casulo, MD⁹, Anne Ségolène Cottereau, MD^10*, Luca Guerra, MD, Prof.^11*, Joshua Olson^12*, Jason T Romancik, MD¹³, Sara Haddadi^14*, Harrison Black^15*, Thomas Trevis^16*, Eric Mou, MD^6*, Tsz Hung Tong^17*, Kamilia Moalem^14*, Anna M. Johnston, FRACP, MBBS, FRCPA¹⁸, Paul J. Hampel, MD¹, Jeffrey Johnson^6*, Steinepreis Elizabeth^19*, Pinguang Yang, MD^9*, Serena Kosciejew, MD^20*, Goodall Elizabeth^21*, Kate Manos, MD^22*, Chan Y. Cheah, MBBS DMSc²³, Ross Salvaris, MBBS^23*, Thomas M. Habermann, MD¹, Peter Martin, MD²⁴, Brad S. Kahl, MD²⁵, Grzegorz S. Nowakowski, MD²⁶, Georgina Hodges, FRACP, MBBS, FRCPA^27*, Loretta Nastoupil^8*, Dipti Talaulikar, PhD, FRACP, FRCPA, MBBS²⁸, Judith Trotman, FRACP²⁹, James R. Cerhan, MD, PhD³⁰, Christopher R. Flowers, MD, MS⁸, Izidore S. Lossos, MD¹⁴, Richard Burack, MD, PhD³¹, Stefano Luminari³², Franck Morschhauser, MD, PhD³³, Stephen M. Ansell, MD, PhD¹ and Matthew J. Maurer, DSc^2*

¹Division of Hematology, Mayo Clinic, Rochester, MN
²Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
⁴Mater Research Institute, University of Queensland, Brisbane, QLD, Australia
⁵Department of Biostatistics, Lymphoma Academic Research Organization (LYSARC), Lyon, France
⁶Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa, Iowa City, IA
⁷Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN
⁸Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Division of Hematology and Medical Oncology, Wilmot Cancer Institute, University of Rochester, Rochester, NY
¹⁰Nuclear Medicine Department, Hopital Cochin, Paris, France
¹¹Nuclear Medicine Division, IRCCS San Gerardo dei Tintori, Monza, Italy
¹²Division of Radiology-Diagnostic, Mayo Clinic, Rochester
¹³Department of Hematology and Medical Oncology, Winship Cancer Institute at Emory University, Atlanta, GA
¹⁴Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
¹⁵Royal Brisbane & Women's Hospital, Brisbane, Australia
¹⁶Mater Hospital Brisbane, South Brisbane, Australia
¹⁷Gold Coast University Hospital, Southport, Australia
¹⁸Royal Hobart Hospital, Hobart, Australia
¹⁹Fiona Stanley Hospital, Murdoch, Australia
²⁰Division of Hematology, Townsville Hospital, Douglas, Australia
²¹Austin Health, Melbourne, Victoria, Australia, Melbourne, AUS
²²Division of Hematology, Flinders Health, Bedford Park, Australia
²³Sir Charles Gairdner Hospital, Perth, Western Australia, Australia
²⁴Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY
²⁵Department of Medicine, Washington University School of Medicine, St. Louis, MO
²⁶Mayo Clinic, Rochester, MN
²⁷Clinical Haematology, Barwon Health, Geelong, Australia
²⁸College of Health and Medicine, Australian National University, Canberra, Australia
²⁹Concord Repatriation General Hospital, University of Sydney, Concord, NSW, Australia
³⁰Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
³¹Pathology and Laboratory Medicine, University of Rochester, Rochester, NY
³²Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy
³³Centre Hospitalier Régional Universitaire de Lille, Lille, France

John M. Burke¹, Ian W. Flinn, MD, PhD², L. Elizabeth Budde³, Aung M. Tun⁴, Steven Liu^5*, Juliana M.L. Biondo, MD⁶, Prachi Jani^6*, Mei Wu^6*, Yong Mun^6*, Vivek S. Chopra^6*, Jessica M. Grindheim^6*, Dana Farinella^6* and Jose C. Villasboas Bisneto, MD⁷

¹Rocky Mountain Cancer Centers, Aurora, CO
²Tennessee Oncology, Nashville, TN
³City of Hope National Medical Center, Duarte, CA
⁴University of Kansas Cancer Center, Kansas City, KS
⁵Alaska Oncology & Hematology, Anchorage, AK
⁶Genentech, Inc., South San Francisco, CA
⁷Mayo Clinic, Rochester, MN

Gloria Iacoboni, MD^1*, Emil Ramsø Kyvsgaard^2*, Victor Navarro Garces, BSc^3*, David A Russler-Germain, MD, PhD⁴, Alejandro Martín García-Sancho^5*, Philip A. Thompson, MBBS, FRACP, FRCPA⁶, Dylan Therwhanger, MD^7*, Itziar Carro, MD^8*, David Quintela^9*, Pilar Gómez^10*, Evelyn Valencia, MD^11*, Gala Vega, MD^12*, Ana Jiménez Ubieto^13*, Mariana Bastos-Oreiro^14*, Angel Serna, MD^1*, Simon Husby, MD, PhD^2*, Beatriz De La Cruz^15*, Jing Luan^16*, Sergi Camarillas, MD^1*, Lucia Medina, MD^17*, Almudena Cabero^18*, Raul Cordoba, MD, PhD¹², Miguel Canales, MD, PhD^11*, Francesc Bosch, MD, PhD¹, Juan-Manuel Sancho, MD, PhD^9*, Ana Maria Sureda Balari, MD, PhD⁸, Stephen Schuster^19*, Martin Hutchings, MD, PhD², Pere Barba, MD¹ and Pau Abrisqueta Costa^1*

¹University Hospital Vall d’Hebron, Barcelona, Spain
²Rigshospitalet, Department of Hematology, Copenhagen, Denmark
³Statistics Unit, Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain
⁴Siteman Cancer Center, Division of Oncology, Washington University School of Medicine, Saint Louis, MO
⁵Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
⁶Department of Clinical Haematology, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
⁷Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
⁸Clinical Hematology Department, Institut Català d’Oncologia-Hospitalet, IDIBELL, Barcelona, Spain
⁹ICO-IJC-Hospital Germans Trias i Pujol, Barcelona, Spain
¹⁰Hospital La Paz, Madrid, Spain
¹¹Department of Hematology, Clínica Universidad de Navarra; Hematology and Oncology Program, Center for Applied Medical Research (CIMA); Instituto de Investigaciones Sanitarias de Navarra (IdiSNA), Pamplona, Spain
¹²University Hospital Fundación Jiménez Díaz, Madrid, Spain
¹³Hematology Department, Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁴Hematology Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain
¹⁵Hematology Department, Hospital Universitario La Paz, Madrid, Spain
¹⁶Department of Medicine, Washington University School of Medicine, St. Louis, MO
¹⁷Hospital Universitario 12 de Octubre, Madrid, Spain
¹⁸Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain
¹⁹Lymphoma Program, Abramson Cancer Center, University of Pennsylvania, Philadelphia PA

Charalampia Kyriakou, MD, PhD¹, Mathilde Fekom^2*, Irma Khvedelidze^2*, Nour Moukalled, MD^3*, Yasmina I.M. Serroukh^4*, Luca Castagna^5*, Silvia Montoto, MD⁶, Anna Ossami Saidy^7*, Stéphanie Nguyen Quoc, MD, PhD^8*, Ka Lung Wu⁹, Péter Reményi, MD^10*, Erfan Nur, MD, PhD¹¹, Malek Benakli, MD^12*, Patrice Chevallier, MD, PhD¹³, Vladan Vucinic, MD^14,15*, Annoek E. C. Broers, MD^16*, Hermann Einsele, MD¹⁷, Olivier Tournilhac^18*, Bertram Glass, MD^7* and Ali Bazarbachi, MD, PhD¹⁹

¹Department of Haematology, University College London Hospital, London, United Kingdom
²European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
³Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut Medical Center, Beirut, Lebanon
⁴Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Leuven, Belgium
⁵Bone Marrow Transplantation Unit AOR Villa Sofia Cervello, Palermo, Italy
⁶St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
⁷Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
⁸Universite Paris IV, Hopital la Pitié-Salpêtrière, Paris, France
⁹ZNA Stuivenberg, Antwerp, Belgium
¹⁰Department of Hematology and Stem Cell Transplantation, South-Pest Central Hospital, Budapest, Hungary
¹¹Department of Hematology, Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
¹²Pierre and Marie Curie Center, Algiers, Algeria
¹³Hematology Department, Nantes University Hospital, Nantes, France
¹⁴Department for Hematology, Cell Therapy, Hemostaseology and Infectious Diseases, University of Leipzig, Leipzig, Saxony, Germany
¹⁵Department of Hematology and Oncology, University Leipzig, Leipzig, Germany
¹⁶Erasmus MC Cancer Institute, Rotterdam, Netherlands
¹⁷Division of Hematology, University Hospital of Wurzburg, Wurzburg, Germany, Würzburg, DEU
¹⁸CHU Estaing, Clermont-Ferrand University Hospital, CLERMONT FERRAND, AURA, France
¹⁹Bone Marrow Transplantation Program/Division of Hematology-Oncology, Department of Internal Medicine, American University of Beirut Dept. of Medicine, Beirut, Lebanon

Jorge J. Castillo, MD¹, Shayna R Sarosiek¹, Andrew R. Branagan, MD², Gottfried von Keudell, MD, PhD³, Catherine A. Flynn, NP^1*, Nina S Budano^1*, Alexandra N. Eurell^1*, Kirsten Meid, MPH^1*, Andres Ramirez-Gamero, MD^1*, Maria Luisa Guerrera, MD¹, Amanda Kofides, BA^1*, Shirong Liu, MD, PhD¹, Xia Liu, MD^1*, Kris Richardson, PhD^1*, Nickolas Tsakmaklis^1*, Christopher J Patterson, MPH, MBA^1*, Zachary R Hunter, PhD¹ and Steven P. Treon, MD, PhD, FRCP⁴

¹Dana-Farber Cancer Institute, Bing Center for Waldenström Macroglobulinemia, Boston, MA
²Center for Multiple Myeloma, Massachusetts General Hospital Cancer Center, Boston, MA
³Beth Israel Deaconess Medical Center, Boston, MA
⁴Dana-Farber Cancer Institute, Dana-Farber Cancer Institute, Inc., Boston, MA

Liliana Tuskova, MD^1,2*, Diana Maláriková, MD^1,2*, Katerina Benesova, MD, PhD^1*, Eva Konirova, MD^1*, Kamila Polgarova, MD, PhD^1*, Petra Blahovcova, Mgr^1,3*, Jana Salkova, MD^1*, Marek Trněný, MD, CSc^1,3 and Pavel Klener^1,2*

¹1st Department of Medicine – Department of Hematology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic
²Institute of Pathological Physiology, First Faculty of Medicine, Charles University, Prague, Czech Republic
³Czech Lymphoma Study Group, Prague, Czech Republic

Francesco Autore, MD, PhD^1*, Alessandra Tedeschi, MD^2*, Giulia Benevolo, MD^3*, Nicolò Danesin, MD^4*, Diana Giannarelli, PhD^5*, Rita Rizzi^6*, Emanuele Cencini, MD^7*, Veronica Mattiello, MD^8*, Isacco Ferrarini, MD, PhD^9*, Jacopo Olivieri, MD^10*, Ilaria Del Giudice^11*, Angela Ferrari^12*, Martina Bullo^13*, Bernardo Rossini^14*, Marina Motta, MD^15*, Dario Marino^16*, Idanna Innocenti, MD, PhD^17*, Luca Stirparo, MD^18*, Diego Petrilli^19*, Pellegrino Musto, MD^20*, Veronica Peri^21*, Giulia Zamprogna^22*, Stefan Hohaus^18*, Anna Maria Frustaci, MD^23*, Francesco Piazza, MD^24*, Simone Ferrero, MD²⁵ and Luca Laurenti, MD^26*

¹Hematology Section, Department of Radiological and Hematological Science, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
²Department of Hematology, Niguarda Cancer Center, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
³Division of Hematology 1, Department of Biotechnology and Health Sciences, University of Torino, Torino, Italy
⁴Azienda Ospedale Università di Padova, Padova, Italy
⁵Biostatistics Unit,, b Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy, Rome, Italy
⁶Università di Bari "Aldo Moro," A.O.U. Consorziale Policlinico di Bari, Bari, Italy
⁷Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
⁸Hematology Department, Foundation IRCCS Ca’ Granda Ospedale Maggiore Policlinico of Milan, Milan, Italy
⁹Department of Engineering for Innovation Medicine, Section of Hematology, University of Verona, Verona, ITA
¹⁰Clinica Ematologica, Centro Trapianti e Terapie Cellulari "Carlo Melzi", Azienda Sanitaria Universitaria Integrata di Udine, Udine, Italy
¹¹Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
¹²Arcispedale Santa Maria Nuova, Reggio Emilia, ITA
¹³AO Ordine Mauriziano di Torino, SCDU Ematologia e Terapie Cellulari, Turin, ITA
¹⁴IRCCS Istituto Tumori "Giovanni Paolo II” Bari, Bari, Italy
¹⁵Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹⁶Oncologia 1, IRCCS Istituto Oncologico Veneto, Padova, Italy
¹⁷Dipartimento di Scienze di Laboratorio ed Ematologiche, Area Ematologia, Fondazione Universitaria Policlinico Agostino Gemelli, Rome, Italy
¹⁸Sezione di Ematologia, Dipartimento di Scienze Radiologiche ed Ematologiche, Università Cattolica del Sacro Cuore, Rome, Italy
¹⁹Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
²⁰Unit of Hematology and Stem Cell Transplantation, AOUC Policlinico, Department of Precision and Regenerative Medicine and  Ionian Area, "Aldo Moro" University School of Medicine, Bari, Italy, Bari, Italy
²¹Hematology Division I, Department of Molecular Biotechnologies and Health Sciences, University of Turin/University Hospital A.O.U. “Città della Salute e della Scienza”, Turin, Italy
²²Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy
²³ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy
²⁴UOC Di Ematologia Azienda Ospedale Università Padova, University of Padua, Padua, Italy
²⁵Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, TO, Italy
²⁶Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Agostino Gemelli University Hospital Foundation IRCCS, Rome, Italy

Sara Ekberg, PhD^1,2*, Ingrid Glimelius, MD, PhD³, Alexandra Albertsson-Lindblad, MD, PhD^4*, Karin Ekstroem Smedby, MD², Mats Jerkeman, MD, PhD⁵ and Caroline E Dietrich^6*

¹Red Door Analytics AB, Stockholm, Sweden
²Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
³Department of Immunology, Genetics and Pathology, Cancer Precision Medicine Unit, Uppsala University, Uppsala, Sweden
⁴Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Lund University, Lund, Sweden
⁵Division of Oncology, Department of Clinical Sciences Lund, Skåne University Hospital, Skane University Hospital, Lund, Skaane Laen, Sweden
⁶Division of Clinical Epidemiology, Department of Medicine Solna, Karolinska Institutet, Stockholm, AL, Sweden

Juying Wei^1*, Wenjuan Yu^2*, Zhengming Jin, M.D.^3*, Keshu Zhou^4*, Haiyan Yang, PhD⁵, Fei Li⁶, Lanfang Li^7*, Bo Zhang^8*, Miao Hu, MD, phd⁹, Yanping Zhang^9*, Xinglu Zhou^9* and Jie Jin, M.D.¹⁰

¹Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
²Zhejiang Provincial Clinical Research Center For Hematological disorders, Hangzhou, China
³Department of Hematology, Collaborative Innovation Center of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, China
⁴Department of Hematology, Henan Cancer Hospital, Zhengzhou, China
⁵Department of Lymphoma, Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, China
⁶Department of Hematology, Jiangxi Clinical Research Center for Hematologic Disease, Jiangxi Provincial Key Laboratory of Hematological Diseases, The First Affiliated Hospital, Jiangxi Medical College, Nanchang, China;, Nanchang, China
⁷Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China
⁸Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China
⁹HealZen Therapeutics Co., Ltd, Hangzhou, China
¹⁰Department of Hematology, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China

Pier Luigi Zinzani, MD, PhD¹, Juan Carlos Dupont, MD^2*, Alessandra Tucci, MD³, Jing Yang, DMD^4*, Yan Xu^4*, Siyang Leng, MD, MS⁴ and Muhit Ozcan, MD⁵

¹Instituto di Ematologia L.E.A., Seragnoli, Bologna, Italy
²CEMIC Hospital Universitario, Buenos Aires, Argentina
³UOC Ematologia, Brescia, Italy
⁴Merck & Co., Inc., Rahway, NJ
⁵Hematology Department, Ankara University School of Medicine, Ankara, Turkey

Ali Mushtaq, MD^1*, Eman Nayaz Ahmed, MBBS^2*, Roaa Aljumaa^2*, Abdel Rahman E’mar, MD^3* and Osamah Badwan, MD^4*

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
³Department of Pediatrics, Cleveland Clinic Foundation, Cleveland, OH
⁴Department of Cardiology, Cleveland Clinic, Cleveland, OH

Julio C. Chavez, MD¹, Guilherme Fleury Perini, MD², Loretta Nastoupil^3*, Judit Mészáros Joergensen, MD, PhD^4*, Pierre Bories^5*, Bijou Fontanet, MD^6*, Pier Luigi Zinzani, MD⁷, Javier Munoz, MD^8*, Daniel Morillo Giles, MD^9*, Cecilia Carpio^10*, Abel Costa, MD^11*, Won Seog Kim, MD^12*, Parth Rao, MD^13*, Bérengère de Moucheron, PharmD^14*, Yang Gang, PhD^15*, Carla Guarinos^14*, Akshay Sudhindra, MD¹³, Michael Pourdehnad, MD¹⁶ and Jean-Marie Michot, MD^17*

¹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
²Department of Medical Oncology, Hospital Israelita Albert Einstein, São Paulo, Brazil
³Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
⁵Early Phase Unit, University Cancer Institute Toulouse Oncopole, Toulouse, France
⁶Institut Bergonié, Bordeaux, France
⁷Institute of Hematology Seràgnoli, University of Bologna, Bologna, Italy
⁸Mayo Clinic, Phoenix, AZ
⁹START Madrid-FJD Early Phase Unit, Fundación Jiménez Díaz University Hospital, Madrid, Spain
¹⁰Department of Hematology, Vall d'Hebron Institute of Oncology (VHIO), University Hospital Vall d'Hebron, Autonomous University of Barcelona (UAB), Barcelona, Spain
¹¹Department of Hematology, D'Or Institute for Research and Education, São Paulo, Brazil
¹²Samsung Medical Center, Division of Hematology-Oncology, Department of Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of (South)
¹³Late Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, Madison, NJ
¹⁴Center for Innovation and Translational Research Europe (CITRE), Bristol Myers Squibb, Seville, Spain
¹⁵Global Biometrics & Data Sciences, Bristol Myers Squibb, Madison, NJ
¹⁶Early Clinical Development, Hematology/Oncology and Cell Therapy, Bristol Myers Squibb, San Francisco, CA
¹⁷Département d'Innovation Thérapeutique et d'Essais Précoces (DITEP), Gustave Roussy Institute of Cancer, Villejuif, France

Ahmed Ludvigsen Al-Mashhadi^1*, Mikkel Runason Simonsen, MSc^2*, Elizabeth Smyth^3*, Rose-Marie Amini^4*, Bente Arboe^5*, James R. Cerhan, MD, PhD⁶, Iman Chanchiri, MD^7*, Chan Y. Cheah, MBBS DMSc³, Jonathan Day^8*, Toby A. Eyre^9*, Anne Ortved Gang^5*, Hervé Ghesquieres, MD, PhD^10,11*, Thomas M. Habermann, MD¹², Eliza A. Hawkes, MD¹³, Steven R. Hwang, MD¹², Ruxandra Irimia^14*, Jennifer B Jørgensen^15*, Arushi Khurana, MBBS¹², Claire Maquet^10*, Ng Layshe, MD^12*, Stephen S. Opat, MBBS, FRACP, FRCPA¹³, Martin Bjerregård Pedersen, MD, PhD^1*, Christian Bjørn Poulsen, MD, PhD^16*, Alexandros Rampotas^17*, Andreea Sima^4*, Karin Ekstroem Smedby, MD¹⁸, Knut Smeland^19*, Gita Thanarajasingam, MD¹², Judith Trotman, FRACP²⁰, Katharine Xing^21*, Simon Østergaard^22*, Diego Villa, MD²³ and Tarec Christoffer El-Galaly, MD, DMSc, Prof²

¹Dept. of Hematology, Aarhus University Hospital, Aarhus, Denmark
²Department of Hematology, Aalborg University Hospital, Aalborg, Denmark
³Department of Haematology, Sir Charles Gairdner Hospital, Perth, Australia
⁴Department of Immunology, Genetics and Pathology, Uppsala University Hospital, Uppsala, Sweden
⁵Department of Hematology, Rigshospitalet, Copenhagen, Denmark
⁶Division of Epidemiology / Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN
⁷Department of Hematology, Odense University Hospital, Odense, Denmark
⁸Department of Internal Medicine, University of Iowa, Iowa City, IA
⁹Department of Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Trust, Oxford, United Kingdom
¹⁰Department of Hematology, Lyon Sud Hospital, Lyon, France
¹¹Department of Hematology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Université Claude Bernard Lyon 1, Lyon, France
¹²Division of Hematology, Mayo Clinic, Rochester, MN
¹³Lymphoma and Related Diseases Registry, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia
¹⁴Carol Davila, University of Medicine and Pharmacy, Bucharest, Romania
¹⁵Department of Internal Medicine, Haematology section, Goedstrup Hospital, Herning, Denmark
¹⁶Department of Hematology, Zealand University Hospital, Roskilde, Denmark
¹⁷Department of Haematology, Cancer and Haematology Centre, Oxford University Hospitals NHS Trust, Oxford, GBR
¹⁸Clinical Epidemiology Division, Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden
¹⁹Department of Oncology, Oslo University Hospital, Oslo, Norway
²⁰Concord Repatriation General Hospital, University of Sydney, Sydney, Australia
²¹Fraser Valley Cancer Centre, BC Cancer, Surrey, BC, Canada
²²Department of Pathology, Zealand University Hospital, Roskilde, Denmark
²³Centre for Lymphoid Cancer, BC Cancer – Vancouver Cancer Centre, Vancouver, BC, Canada

Luca Arcaini, MD^1*, Michele Merli, MD^2*, Sara Rattotti, MD^3*, Maria Elena Nizzoli, MD^4*, Vittoria Tarantino, MD^5*, Federica Cavallo^6*, Annalisa Talami, MD^7*, Roberta Murru, MD^8*, Marina Deodato, MD^9*, Emanuele Cencini, MD^10*, Francesca Re, MD^11*, Carlo Visco, MD^12*, Marcia Torresan Delamain, PhD, MD^13*, Michele Spina, MD^14*, Ombretta Annibali, MD^15*, Alessandro Pulsoni, MD^16*, Andrés José María Ferreri, MD¹⁷, Caterina Stelitano, MD^18*, Emilia Cappello, MD^19*, Gianmarco Favrin^19*, Martina La Fauci, MD^20*, Luigi Marcheselli^21*, Marco Paulli, MD^22* and Stefano Luminari^23,24

¹Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²Hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
³Fondazione IRCCS Policlinico San Matteo and University of Pavia, Pavia, Italy
⁴Hematology Unit, Azienda USL- IRCCS di Reggio Emilia, Reggio Emilia, Italy
⁵Division of Hematology, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
⁶Department of Molecular Biotechnology and Health Sciences, Hematology Division, University of Torino, Torino, Italy
⁷Clinical and Experimental Medicine Doctorate School, Università degli Studi di Modena e Reggio Emilia, Reggio Emilia, Italy
⁸Hematology and Stem Cell Transplantation Unit, Ospedale Oncologico A. Businco, ARNAS G. Brotzu, Cagliari, Italy
⁹Dipartimento di Ematologia, ASST Grande Ospedale Metropolitano Niguarda, Niguarda Cancer Center, Milan, Italy, Milano, Italy
¹⁰Division of Hematology, Azienda Ospedaliera Universitaria Senese & University of Siena, Siena, Italy
¹¹Division of Hematology, Azienda Ospedaliera Universitaria di Parma, Parma, Italy
¹²Hematology and Bone Marrow Transplant Unit, Department of Engineering for Innovative Medicine, University of Verona, Verona, Italy
¹³Faculty of Medicine of Minas Gerais, Belo Horizonte, AC, BRA
¹⁴Division of Medical Oncology, IRCCS Centro Di Riferimento Oncologico, Aviano, Italy
¹⁵Division of Hematology, Stem Cell Transplantation,, Fondazione Policlinico Universitario Campus Bio Medico, Roma, Italy
¹⁶Division of Hematology, Sapienza University – Polo Pontino, Department of Translational and Precision Medicine, S.M. Goretti Hospital, Latina, Italy
¹⁷Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
¹⁸Division of Hematology, Grande Ospedale Metropolitano, Bianchi Melacrino Morelli, Reggio Calabria, Italy
¹⁹Department of Molecular Medicine, University of Pavia, Pavia, Italy
²⁰Fondazione IRCCS Policlinico San Matteo, Division of Hematology, Pavia, Italy
²¹Fondazione Italiana Linfomi, Clinical Trial Office, Modena, Italy
²²Pathology Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
²³Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy
²⁴Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy

Shrinjaya B Thapa, MD¹, David Kaldas, MD¹, Jose Laborde^2*, Shrikar Modukuri^1*, Filip Ionescu, MD, MS¹, Brandon Blue, MD³, Julio C. Chavez, MD⁴, Melissa Alsina, MD¹, Celeste M. Bello, MD⁵, Javier Pinilla-Ibarz, MD, PhD¹, Kenneth H. Shain, MD, PhD⁶, Rachid C. Baz⁷ and Ariel Grajales-Cruz, MD¹

¹Moffitt Cancer Center, Tampa, FL
²Moffitt Cancer Center, Tampa
³Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴Department of Malignant Hematology, H. Lee Moffitt Cancer Center and Research Institute, Lutz, FL
⁵H Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁶H. Lee Moffitt Cancer Center, Tampa, FL
⁷Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL

Nathan Brandwein, MSc, PharmD^1*, Kevin Thai, BScPharm^2*, Alisha Shivji, BScPharm^2*, Alexandra Charlton, PharmD^2* and Jingyu Bu, MSc^2*

¹Alberta Health Services, Edmonton, AB, Canada
²Alberta Health Services, Calgary, Canada

Oliver M Tomkins, BMBS^1*, Nicole Japzon^1*, Jahanzaib Khwaja¹, Jindriska Lindsay, FRCP FRCPath^1*, Charalampia Kyriakou, MD, PhD¹ and Shirley D'Sa, FRCP FRCPath MD(Res)^2*

¹UCLH Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²University College London Hospitals NHS Foundation Trust, London, United Kingdom

Anath Lionel, MD, PhD¹, Sherif Seif, MD^2*, Xiaowen Sun^3*, Lei Feng, MS^3*, Lorenzo Gensini, MD^2*, Bria Gabriel^2*, Lauren S. Lewis^2*, Hima Bansal, PhD^2*, Melody R. Becnel, MD², Mahmoud R. Gaballa, MD², Hans C. Lee, MD², Oren Pasvolsky, MD², Krina K. Patel, MD, MSc², J Christine Ye, MD, MSc², Keyur P. Patel, MBBS, PhD⁴, Donna M. Weber, MD², Robert Z. Orlowski, MD, PhD² and Sheeba K. Thomas, MD²

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Oakville, ON, Canada
²Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX

Ewa Paszkiewicz-Kozik^1*, Claudia Moreira^2*, Mehmet Turgut, MD^3*, Marcelo Garrido^4*, Ingrid Glimelius, MD, PhD^5,6, Seung Tae Lee, MD, PhD⁷, Yazeed Sawalha, MD⁸, Yixin Ren^9*, Katherine Ryland, PhD⁹, Uzor C. Ogbu, MBBS, PhD⁹ and Diego Villa, MD¹⁰

¹Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
²Instituto Português de Oncologia do Porto Francisco Gentil Epe, Porto, Portugal
³Department of Hematology, Mayis University Medical School, Samsun, Turkey
⁴SAGA Clinical Trial Center, Universidad Mayor, Santiago, Chile
⁵Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
⁶Akademiska sjukhuset-Blod-och tumorsjukdomar, Uppsala, Sweden
⁷University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
⁸The James Cancer Hospital and Solove Research Institute, The Ohio State University, Columbus, Columbus, OH
⁹Merck & Co., Inc., Rahway, NJ
¹⁰Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada

Kikuaki Yoshida^1*, Noriko Iwaki^2*, Nobuhiko Yamauchi^1*, Yusuke Koba^1*, Yuko Shirouchi^1*, Yuko Ishihara^1*, Yuko Mishima^1*, Shinichi Makita^2*, Suguru Fukuhara^2*, Wataru Munakata, MD, PhD^2*, Norihito Inoue^3,4*, Naoko Tsuyama^3,4*, Senzo Taguchi, MD, PhD^5*, Takashi Terauchi^6*, Hideki Tsuji^7*, Akiko Miyagi-Maeshima^8*, Shigenobu Suzuki^9*, Hiroshi Igaki^10*, Kengo Takeuchi^3,4,11*, Koji Izutsu, MD, PhD¹² and Dai Maruyama, MD, PhD¹

¹Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
²Department of Hematology, National Cancer Center Hospital, Tokyo, Japan
³Division of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
⁴Clinical Pathology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁵Department of Radiation Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁶Department of Nuclear Medicine, Cancer Institute Hospital, Japanese Foundation For Cancer Research, Tokyo, Japan
⁷Department of Ophthalmology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
⁸Department of Diagnostic Pathology, National Cancer Center Hospital, Tokyo, Japan
⁹Department of Ophthalmologic Oncology, National Cancer Center Hospital, Tokyo, Japan
¹⁰Department of Radiation Oncology, National Cancer Center Hospital, Tokyo, Japan
¹¹Pathology Project for Molecular Targets, Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan
¹²National Cancer Center Hospital, Tokyo, Japan

Yasmina I.M. Serroukh^1*, Mathilde Fekom^2*, Irma Khvedelidze^2*, Ben Carpenter, MD^3*, Herve Ghesquieres, MD, PhD^4*, Ludovic Gabellier, MD, PhD^5*, Jacques-Olivier Bay, MD, PhD^6*, Didier Blaise, MD^7*, Maurizio Musso^8*, Patrice Chevallier, MD, PhD⁹, Edouard Forcade, MD, PhD^10*, Anne Huynh, MD^11*, Andy Peniket^12*, Marek Trněný, MD, CSc¹³, Catherine Flynn^14*, Shankara Paneesha^15*, Andrew Clark^16*, Charalampia Kyriakou, MD, PhD³, Anna Ossami Saidy^17*, Bertram Glass, MD^17*, Luca Castagna^18*, Silvia Montoto, MD¹⁹ and Ali Bazarbachi, MD, PhD²⁰

¹Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Leuven, Belgium
²European Bone Marrow Transplantation Lymphoma Working Party, Paris, France
³University College London Hospitals NHS Foundation Trust, London, United Kingdom
⁴Hospices Civils de Lyon, Lyon, France
⁵Hematology Departement, CHU Montpellier University Hospital, UMR-CNRS 5535, Montpellier, France
⁶CHU ESTAING, Clermont-Ferrand, France
⁷Programme de Transplantation & Therapie Cellulaire, Marseille, France
⁸Hematology Unit, Clinica La Maddalena Division of Onco-Hematology and Stem Cell Transplantation, Palermo, Italy
⁹CHU de Nantes, Nantes, France
¹⁰Service d'Hématologie Clinique et Thérapie Cellulaire, CHU Bordeaux, Bordeaux, France
¹¹Hematology Department, Institut Universitaire du Cancer Toulouse - Oncopole, Toulouse, France
¹²Oxford Radcliffe, Oxford, United Kingdom
¹³Charles University Hospital, Prague, Czech Republic
¹⁴Department of Haematology, St. James' Hospital, Dublin, Ireland
¹⁵Birmingham Centre for Cellular Therapy and Transplant (BCCTT), Birmingham, United Kingdom
¹⁶Glasgow Royal Infirmary, Glasgow, United Kingdom
¹⁷Department of Hematology and Cell Therapy, Helios Klinikum Berlin-Buch, Berlin, Germany
¹⁸Bone Marrow Transplantation Unit AOR Villa Sofia Cervello, Palermo, Italy
¹⁹St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom
²⁰American University of Beirut Dept. of Medicine, Beirut, Lebanon

Alexander P. Boardman, MD^1*, Juan Luis Reguera, MD^2*, Paul Spin^3*, Pearl Wang, MSc^3*, Lamees Almuallem, MS, MPH^3*, Jenna Ellis, MSc^3*, Jamie Zheng, PharmD^4*, Jinender Kumar, MS^4*, Thalia Farazi, MD, PhD⁵, Alejandro Martín García-Sancho^6* and Koji Izutsu, MD, PhD⁷

¹Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS) / CSIC, Universidad de Sevilla, Seville, Spain
³EVERSANA, Burlington, ON, Canada
⁴Bristol Myers Squibb, Princeton, NJ
⁵Bristol Myers Squibb, San Francisco, CA
⁶Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain
⁷National Cancer Center Hospital, Tokyo, Japan

Judith Trotman, FRACP¹, Pier Luigi Zinzani, MD, PhD², Krimo Bouabdallah, MD^3*, Shanmei Liao^4*, Adam Greenbaum, MD, PhD^5*, Laura Dima^6* and Laurent Dumartin^6*

¹Department of Hematology, Concord Repatriation General Hospital, Sydney, NSW, Australia
²University of Bologna, Bologna, Italy
³CHU Bordeaux, Pessac, France
⁴BeiGene (Shanghai) Co, Ltd, Shanghai, China
⁵BeiGene USA, Inc, San Mateo, CA
⁶BeiGene, Paris, France

Kazutaka Suzuki^1*, Kana Miyazaki, MD, PhD¹, Naoko Asano, MD, PhD², Hiroyuki Takahashi, MD, PhD^3*, Nobuhiro Hiramoto, MD, PhD^4*, Hiro Tatetsu, MD, PhD⁵, Ilseung Choi, MD, PhD⁶, Hiroshi Arima, MD, PhD^7*, Toshiki Uchida, MD, PhD^8*, Dai Maruyama, MD, PhD⁹, Takeharu Kato, MD, PhD^10*, Junji Hiraga, MD, PhD^11*, Nobuhiro Kanemura, MD, PhD¹², Tohru Murayama, MD, PhD^13*, Shingo Yano, MD, PhD¹⁴, Shunsuke Ito, MD^15*, Naoki Takahashi, MD, PhD^16*, Shinsuke Iida, MD, PhD¹⁷, Tetsu Kobayashi, MD, PhD^18*, Motoshi Takao, MD, PhD^19*, Isao Tawara, MD, PhD¹ and Motoko Yamaguchi, MD, PhD²⁰

¹Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan
²Department of Molecular Diagnostics, Nagano Prefectural Shinshu Medical Center, Suzaka, Japan
³Department of Hematology and Medical Oncology, Kanagawa Cancer Center, Yokohama, Japan
⁴Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan
⁵Department of Hematology, Rheumatology and Infectious Diseases, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
⁶Department of Hematology and Cell therapy, NHO Kyushu Cancer Center, Fukuoka, Japan
⁷Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
⁸Department of Hematology and Oncology, Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya, Japan
⁹Department of Hematology Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
¹⁰Department of Hematology, Nagasaki University Hospital, Nagasaki, Japan
¹¹Department of Hematology, Toyota Kosei Hospital, Toyota, Japan
¹²Department of Hematology and Infectious Disease, Gifu University Hospital, Gifu, Japan
¹³Department of Hematology, Hyogo Cancer Center, Akashi, Japan
¹⁴Department of Clinical Oncology and Hematology, The Jikei University School of Medicine, Tokyo, Japan
¹⁵Department of Hematology, Shimane University Hospital, Izumo, Japan
¹⁶Department of Hematology, International Medical Center, Saitama Medical University, Saitama, Japan
¹⁷Nagoya City University Institute of Medical and Pharmaceutical Sciences, Nagoya, Japan
¹⁸Department of Pulmonary and Critical Care Medicine, Mie University Graduate School of Medicine, tsu, Japan
¹⁹Department of Thoracic and Cardiovascular Surgery, Mie University Graduate School of Medicine, tsu, Japan
²⁰Department of Hematological Malignancies, Mie University Graduate School of Medicine, Tsu, Japan

Shirley D’Sa, MD^1*, Meletios A. Dimopoulos, MD², Wojciech Jurczak, MD, PhD³, Paula Marlton^4*, Stephen P. Mulligan, MBBS, PhD, FRACP, FRCPA⁵, Bjorn E Wahlin, MD, PhD⁶, Magdalena Sobieraj-Teague^7*, Andrew W. Roberts, MBBS, PhD⁸, Constantine S. Tam, MD, MBBS⁹, Jorge J. Castillo, MD¹⁰, Heather Allewelt, MD^11*, Radha Prathikanti, MPH, MBA^11*, Wai Y Chan^11*, Tian Tian, PhD^11*, Jingjing Schneider^11*, Remus Vezan, MD, PhD^11* and Stephen S. Opat, MBBS, FRACP, FRCPA¹²

¹Centre for Waldenström’s Macroglobulinemia and Associated Disorders, University College London Hospital Foundation Trust, London, United Kingdom
²General Hospital of Athens-Alexandra, Llisia, Greece
³Maria Sklodowska-Curie National Research Institute of Oncology, Krakow, Malopolskie, Poland
⁴Princess Alexandra Hospital and University of Queensland, Brisbane, QLD, Australia
⁵Royal North Shore Hospital, Sydney, NSW, Australia
⁶Karolinska Universitetssjukhuset Solna, Solna, Sweden
⁷Flinders Medical Centre, Bedford Park, SA, Australia
⁸The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, Australia
⁹Alfred Hospital and Monash University, Melbourne, VIC, Australia
¹⁰Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA
¹¹BeiGene USA, Inc, San Mateo, CA
¹²Lymphoma Research Group, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia

Izidore S. Lossos, MD¹, Geoffrey Shouse, PhD, DO², Alvaro J Alencar, MD³, Safia Sawleh, M.D.^4*, David S. Lessen, MD⁴, Craig H. Moskowitz, MD⁵, Jennifer Rose Chapman-Fredricks, MD^6*, Isildinha M. Reis, PhD^7*, Russ Kuker, MD^8* and Juan Pablo Alderuccio, MD⁴

¹Division of Hematology, Sylvester Comprehensive Cancer Center, Miami, FL
²City of Hope Cancer Center, Duarte, CA
³Sylvester Comprehensive Cancer Center, Division of Hematology, University of Miami, Miller School of Medicine, Miami Beach, FL
⁴Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁵Department of Medicine, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL
⁶Department of Pathology, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL
⁷Department of Public Health Sciences and Biostatistics and Bioinformatics Shared Resource, University of Miami Miller School of Medicine, Miami, FL
⁸Department of Radiology, Division of Nuclear Medicine, University of Miami, Miller School of Medicine, Miami, FL

Lijuan Deng^1*, Yanyan Liu, MD, PhD^2*, Ningjing Lin, MD^3*, Zhihua Yao^4*, Jiuyang Zhang^4*, Wei Meng^5*, Qiying Lu^5*, Wenzhi Tian^5*, Jun Zhu, PhD⁶ and Yuqin Song, MD⁷

¹Department of Lymphoma, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Peking University Cancer Hospital & Institute, Beijing, China
²Department of Internal Medicine, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
³Department of Lymphoma, Peking University Cancer Hospital and Institute, Beijing, China
⁴Lymphatic Comprehensive Internal Medicine Ward, Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China
⁵ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Shanghai, China
⁶Department of Lymphoma, Peking University Cancer Hospital, Beijing, Beijing, China
⁷Key Laboratory of Carcinogenesis and Translational Research, Department of Lymphoma, Peking University Cancer Hospital, Beijing, China

Catherine Thieblemont, MD¹, Martin Dreyling, MD², Michael J. Dickinson, MBBS, DMedSci³, Joaquín Martínez-Lopez^4*, Arne Kolstad, MD, PhD^5*, Jason Butler, MBBS^6*, Monalisa Ghosh, MD⁷, Leslie L. Popplewell, MD, MPH⁸, Julio C. Chavez, MD⁹, Emmanuel Bachy, MD, PhD¹⁰, Koji Kato, MD, PhD¹¹, Hideo Harigae, MD, PhD¹², Marie José Kersten^13*, Charalambos Andreadis, MD, MS^14*, Peter A. Riedell, MD^15*, Phoebe Joy Ho, MBBS¹⁶, Jose Antonio Pérez-Simón, MD, PhD¹⁷, Andy Chen, MD, PhD¹⁸, Loretta Nastoupil^19*, Bastian von Tresckow^20,21, Andrés José María Ferreri, MD²², Takanori Teshima, MD, PhD²³, Piers E.M. Patten, MBChB, FRCP, FRCPath, PhD^24*, Joseph P. McGuirk, DO²⁵, Fritz Offner, MD, PhD²⁶, Andreas Viardot, MD, PhD²⁷, Pier Luigi Zinzani, MD, PhD^28,29, Ram Malladi, MD, PhD^30*, Aiesha Zia, MSc^31*, Rakesh Awasthi, PhD^32*, Davide Germano, PhD^31*, Roberto Javier Ramos, MD^32*, Pei Hsu, MD^31*, Stephen J. Schuster, MD³³ and Nathan H. Fowler, MD^34*

¹Service Hémato-Oncologie, Hôpital Saint- Louis, Paris, France
²Department of Medicine III, Ludwig Maximilian University Hospital, Munich, Germany
³Peter MacCallum Cancer Centre, Royal Melbourne Hospital and The University of Melbourne, Melbourne, VIC, Australia
⁴Hospital Universitario 12 de Octubre, CIBER-ONC CB16/12/00369, CNIO, Madrid, Spain
⁵Oslo University Hospital, Oslo, Norway
⁶Royal Brisbane Hospital, Herston, QLD, Australia
⁷Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
⁸Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Atlanta, GA
⁹Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL
¹⁰Clinical Hematology, Hospices Civils de Lyon and Claude Bernard Lyon 1 University, Lyon, France
¹¹Department of Hematology, Oncology, and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka Prefecture, Japan
¹²Department of Hematology, Tohoku University Graduate School of Medicine, Sendai, Japan
¹³Cancer Center Amsterdam, Amsterdam University Medical Centers, University of Amsterdam, Amsterdam, Netherlands
¹⁴Helen Diller Family Comprehensive Cancer Center, University of California San Francisco, San Francisco, CA
¹⁵David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL
¹⁶Royal Prince Alfred Hospital and University of Sydney, Sydney, NSW, Australia
¹⁷Department of Hematology, University Hospital Virgen del Rocio-IBIS, Universidad de Sevilla, Sevilla, Spain
¹⁸Oregon Health and Science University, Portland, OR
¹⁹The University of Texas MD Anderson Cancer Center, Houston, TX
²⁰Department I of Internal Medicine, Medical Faculty and University Hospital Cologne, University of Cologne, Cologne, Germany
²¹University Hospital Essen, University of Duisburg-Essen, Department of Hematology and Stem Cell Transplantation, West German Cancer Center (WTZ), Essen, Germany
²²Unit of Lymphoid Malignancies, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy
²³Department of Hematology, Hokkaido University, Sapporo, Japan
²⁴King’s College London, London, United Kingdom
²⁵University of Kansas Medical Center, Westwood, KS
²⁶Universitair Ziekenhuis Gent, Gent, Belgium
²⁷Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
²⁸Universitaria di Bologna, Istituto Di Ematologia,, Bologna, Italy
²⁹Institute of Hematology "Seràgnoli" University of Bologna, Bologna, Italy
³⁰Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom
³¹Novartis Pharma AG, Basel, Switzerland
³²Novartis Pharmaceuticals, East Hanover, NJ
³³Abramson Cancer Center, University of Pennsylvania, Philadelphia, PA
³⁴BostonGene, Waltham, MA

Mitsuaki Oura, M.D.^1*, Daisuke Ikeda, MD^1,2*, Chiho Misono^3*, Shuichi Aikawa^3*, Fuminari Fujii, M.D.^1*, Hajime Sakuma, M.D.^1*, Masanori Toho, MD^1*, Atsushi Uehara, MD^1*, Rikako Tabata, M.D.^1*, Kentaro Narita, M.D.^4*, Tomohisa Watari^3*, Yoshihito Otsuka, Ph.D.^3*, Masami Takeuchi, M.D.^1* and Kosei Matsue, M.D., Ph.D.¹

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan
²Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
³Department of Laboratory Medicine, Kameda Medical Center, Chiba, Japan
⁴Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan

Yufu Li, MD^1*, Wei Xu, MD, PhD^2*, Caixia Li, MD^3*, Pengcheng He, MD^4*, Wei Yang, MD^5*, Xiangmin Tong, MD^6*, Ying Wang, MD^7*, Hongchan Zhang^8*, Caixia Sun, MD^8*, Zejuan Sheng, PhD^8*, Jean Fan, MD^9* and Jianyong Li, MD²

¹Department of Hematology, Henan Cancer Hospital, Zheng Zhou, China
²Department of Hematology, The First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital, Nanjing, China
³Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, China
⁴Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, China
⁵Department of Hematology, Shengjing Hospital of China Medical University, Shenyang, China
⁶Department of Hematology, Affiliated Hangzhou First People’s Hospital, School of Medicine,Westlake University, Hangzhou, China
⁷Affiliated Hangzhou First People’s Hospital, School of Medicine,Westlake University, Hangzhou, China
⁸TransThera Sciences (Nanjing), Inc., Nanjing, China
⁹TransThera Sciences (US),Inc., Maryland

Henry Ogbeifun, MD, MPH^1*, Supreet Kaur, MD², Zohra Nooruddin, MD³, Cynthia I Nguyen, BS^4*, Corbyn M Gilmore, BS, MS^4*, Adriana M Vargus, BS, PharmD^4*, Kathleen Franklin, BSN, RN^3*, Xavier Jones, BS^3* and Christopher Frei, PharmD, MS^5*

¹University of Texas Health Science Center. Pharmacotherapy Education & Research Center (PERC), University of Texas Autin, San Antonio, TX
²UT Health Cancer Center, Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, TX
³South Texas Veterans Health Care System, San Antonio, TX
⁴University of Texas Austin, San Antonio, TX
⁵University of Texas Health Science Center. Pharmacothery Education & Research Center (PERC), Long School of Medicine, University of Texas Health San Antonio, San Antonio, TX

Preetesh Jain, MD, MBBS, PhD, DM¹, Chi Young Ok, MD², Jason R. Westin, MD³, Holly A Hill, MS^4*, Ranjit Nair, MD⁵, Swami P. Iyer, MD¹, Ahmed Fetooh, MD^6*, Hun Ju Lee, MD¹, Sairah Ahmed, MD¹, Rashmi Kanagal-Shamanna, MD⁷, Fatima Z Jelloul^8*, Luis Malpica, MD^1*, Yang Liu, Ph.D^1*, Yijing Li, BS, MS^1*, Lei Feng, MS^9*, Maria Badillo^6*, Selvi Thirumurthi, MD^10*, Anita Deswal, MD, MPH, MBBS^11*, Cezar Iliescu, MD^12*, Vinh Quang Nguyen, MD^13*, Anastasiia A. Bolshakova^14*, Dmitry Tabakov, PhD^15*, Michael G Goldberg, PhD^16*, Andrey Tyshevich, MSc^15*, Tatiana Vasileva^17*, Daria Shavronskaya^16*, Krystle Nomie, PhD^18*, Guilin Tang, MD, PhD^8*, Keyur P. Patel, MBBS, PhD⁸, Francisco Vega, MD, PhD¹⁹, L. Jeffrey Medeiros, MD⁸, Christopher R. Flowers, MD, MS¹ and Michael Wang, MD¹

¹Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
²Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
³The University of Texas M D Anderson Cancer Center, Houston, TX
⁴Departments of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁵Department of Lymphoma/Myeloma, University of Texas MD Anderson Cancer Center, Houston, TX
⁶Lymphoma/ Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
⁷Department of Hematopathology, The University of Texas M. D. Anderson Cancer Center, Houston, TX
⁸Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
⁹Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁰Gastroenterology, The University of Texas MD Anderson Cancer Center, houston, TX
¹¹Cardiology, University of Texas MD Anderson Cancer Center, Houston, TX
¹²Cardiology, The University of Texas MD Anderson Cancer Center, houston, TX
¹³Geriatrics, The University of Texas MD Anderson Cancer Center, Houston, TX
¹⁴BostonGene, Corp, Waltham, MA
¹⁵BostonGene, Corp., Waltham, MA
¹⁶BostonGene,Corp, Waltham, MA
¹⁷BostonGene,Corp, waltham, MA
¹⁸BostonGene Corp., Waltham, MA
¹⁹MD Anderson Cancer Center , Houston, TX

Oliver M Tomkins, BMBS^1*, Jahanzaib Khwaja¹, Nicole Japzon^1*, Shiwen Koay, MRCP PhD^2*, Chandrashekar Hoskote, MBBS MD FRCR^3*, Charalampia Kyriakou, FRCP FRCPath PhD^1*, Jindriska Lindsay, FRCP FRCPath^1*, Michael P Lunn, FRCP PhD^2* and Shirley D'Sa, FRCP FRCPath MD(Res)^4*

¹UCLH Centre for Waldenströms Macroglobulinaemia and Related Conditions, University College London Hospitals NHS Foundation Trust, London, United Kingdom
²Centre for Neuromuscular Diseases, National Hospital for Neurology and Neurosurgery, London, United Kingdom
³Lysholm Department of Neuroradiology, National Hospital for Neurology and Neurosurgery, London, United Kingdom
⁴University College London Hospitals NHS Foundation Trust, London, United Kingdom

Nikhil P. Mankuzhy, MD^1*, Brandon S. Imber, MD, MA¹, Paige Pammer, BS^1*, Beatrice Fregonese, MPH^1*, Adriana Cajo^1*, Gustav Cederquist, MD, PhD^1*, Alexandra Dreyfuss, MD, MSTR^1*, Kaitlyn Lapen, MD^1*, Roshal R. Patel, MD^1*, Zachary R. Moore, MD, PhD^1*, Carla Hajj, MD^1*, Gilles Salles, MD, PhD² and Joachim Yahalom, MD¹

¹Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
²Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Na Zhang, Master of Medicine^1*, Jiegang Xu^2*, Chengxin Luo^2*, Dongfeng Zeng^1*, Shuangnian Xu^2* and Xi Li^1*

¹Department of Hematology, Daping Hospital, Third Military Medical University (Army Medical University), Chongqing, China, Chongqing, China
²Department of Hematology, Southwest Hospital, Third Military Medical University,(Army Medical University), Chongqing, China, Chongqing, China

Fuminari Fujii, M.D.^1*, Daisuke Ikeda, M.D.^2*, Hajime Sakuma, M.D.^3*, Mitsuaki Oura, M.D.^3*, Masanori Toho, MD^3*, Rikako Tabata, M.D.^1*, Kentaro Narita, M.D.^1*, Masami Takeuchi, M.D.^3* and Kosei Matsue, M.D., Ph.D.³

¹Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Japan
²Department of Hematology and Oncology, Okayama University Hospital, Okayama, Japan
³Division of Hematology/Oncology, Kameda Medical Center, Kamogawa, Chiba, Japan

Marco Ladetto, MD¹, Rita Tavarozzi^2*, Matthew Ku, MBBS, PhD^3*, Luca Arcaini, MD^4*, Carola Boccomini^5*, Beatrice Casadei, MD^6*, Annalisa Chiarenza^7,8*, Annarita Conconi^9*, Ilaria Del Giudice^10*, Michele Merli^11*, Maria Elena Nizzoli, MD^12,13* and Stefano Luminari^14,15

¹Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, Piedmont, Italy
²Department of Translational Medicine, Università del Piemonte Orientale ed SCDU Ematologia AOU SS Antonio e Biagio e Cesare Arrigo, Alessandria, ITA
³St Vincent's Hospital, University of Melbourne, Melbourne, Australia
⁴Department of Molecular Medicine, University of Pavia and Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy
⁵SC Ematologia, AOU Città della Salute e della Scienza, Torino, Italy
⁶IRCCS Azienda Ospedaliero-Universitaria di Bologna  Istituto di Ematologia “Seràgnoli”, Bologna, Italy
⁷Hematology and Bone Marrow Transplatation Unit, U.O.C. Ematologia, A.O.U. Poiliclinico G.Rodolico-S.Marco, Catania, Italy
⁸Division of Hematology, AOU "Policlinico PO Rodolico- San Marco", Catania, Italy
⁹SSD Ematologia, Nuovo Ospedale degli Infermi, Biella, Italy
¹⁰Hematology, Department of Translational and Precision Medicine, Sapienza University, Roma, Italy
¹¹Hematology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy
¹²Hematology Unit, Azienda USL- IRCCS di Reggio Emilia, Reggio Emilia, Italy
¹³Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, Modena, Italy
¹⁴Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Reggio Emilia, Italy
¹⁵Hematology, Azienda Unità Sanitaria Locale IRCCS of Reggio Emilia, Reggio Emilia, Italy

Stephanie Herold^1*, Anke Ohler^2*, Marie-Kristin Tilch, MD^2*, Christian Schmidt, MD^3*, Michael Unterhalt^4*, Eva Hoster^5*, Elisabeth Hoenig^6*, Susanne Singer^7*, Carlo Visco, MD^8*, Marco Ladetto⁹, Alessandra Tucci, MD¹⁰, Christiane Pott, MD^11*, Georg Hess, MD^2* and Martin Dreyling, MD⁴

¹Department of Hematology and Medical Oncology, University Medical School of the Johannes Gutenberg-University Mainz, Mainz, AL, Germany
²Department of Hematology and Medical Oncology, University Medical School of the Johannes Gutenberg-University Mainz, Mainz, Germany
³Department of Medicine III, LMU University Hospital, LMU Munich, Munich, Germany
⁴Department of Internal Medicine III, University Hospital, Ludwig Maximilian University (LMU) Munich, Munich, Germany
⁵Institute for Medical Information Processing, Biometry, and Epidemiology (IBE), Faculty of Medicine, LMU Munich, Munich, DEU
⁶Interdisciplinary Centre for Clinical Trials (IZKS), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
⁷Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany
⁸Department of Engineering for Innovation Medicine/Section of Hematology, University of Verona, Verona, Italy
⁹Department of Translational Medicine, Università del Piemonte Orientale SCDU Ematologia SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy
¹⁰Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
¹¹Department of Internal Medicine II (Hematology/Oncology), University Hospital Schleswig-Holstein, Kiel, Germany

Madhav R Seshadri, MD¹, Chiung-Yu Huang, PhD^1*, Hildy Donner^2*, William B. Pearse, MD^3*, Patricia A. Young, MD⁴, Monica Mead, MD⁵, Naseem S. Esteghamat, MD⁶, Christine Thacker^7*, Lauren Nguyen^1*, Weiyun Ai, MD PhD¹, Michael A Spinner, MD¹, Lawrence David Kaplan, MD¹ and Charalambos Andreadis, MD^1,8

¹University of California San Francisco, San Francisco, CA
²University of California, Davis, Sacramento, CA
³Division of Hematology-Oncology, Department of Medicine, University of California San Diego School of Medicine, San Diego, CA
⁴Department of Medicine/Division of Hematology and Oncology, UCLA Medical Center, Los Angeles, CA
⁵UCLA Medical Center, Santa Monica, CA
⁶Department of Internal Medicine, Division of Malignant Hematology/Cellular Therapy and Transplantation, University of California, Davis Medical Center Comprehensive Cancer Center, Sacramento, CA
⁷University of California San Francisco, San Francsico, CA
⁸Helen Diller Family Comprehensive Cancer Center, UCSF, San Francisco, CA